ID   NCU-L-3
AC   CVCL_0G12
SY   NCU-L3; Nagoya City University-Leukemia-3
DR   Wikidata; Q54908293
RX   CelloPub=CLPUB00229;
RX   PubMed=9738977;
RX   PubMed=19358282;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 30-46 hours (CelloPub=CLPUB00229).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 10
//
RX   CelloPub=CLPUB00229;
RA   Nitta M., Iida S., Komatsu H., Maeda H., Banno S., Wakita A.,
RA   Iwaki O., Takeuchi G., Takada K., Mitomo Y., Yamamoto M., Koike K.,
RA   Ueda R., Shamoto M.;
RT   "A novel cell line of acute lymphoblastic leukemia (ALL-L3, Burkitt's
RT   type), NCU-L-3.";
RL   Nagoya Med. J. 37:101-109(1992).
//
RX   PubMed=9738977; DOI=10.1111/j.1349-7006.1998.tb03275.x;
RA   Takizawa J., Suzuki R., Kuroda H., Utsunomiya A., Kagami Y., Joh T.,
RA   Aizawa Y., Ueda R., Seto M.;
RT   "Expression of the TCL1 gene at 14q32 in B-cell malignancies but not
RT   in adult T-cell leukemia.";
RL   Jpn. J. Cancer Res. 89:712-718(1998).
//
RX   PubMed=19358282; DOI=10.1002/ijc.24351;
RA   Inagaki A., Ishida T., Yano H., Ishii T., Kusumoto S., Ito A., Ri M.,
RA   Mori F., Ding J.-M., Komatsu H., Iida S., Ueda R.;
RT   "Expression of the ULBP ligands for NKG2D by B-NHL cells plays an
RT   important role in determining their susceptibility to
RT   rituximab-induced ADCC.";
RL   Int. J. Cancer 125:212-221(2009).
//